Price
No data yet.
Social Signal Score
Analyst Ratings
1 analystRevenue
$38.40M+35.36%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Trent Green
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Employees
- 357
- Beta
- 0.38
- Country
- US
- Piotroski score
- 7 / 9 (Strong)
- Altman Z-score
- 3.17
Financials
Revenue
$38.40M+35.4%Net Income
$4.70M-17.1%EBITDA
$11.00M+11.0%Free Cash Flow
$6.98M-11.8%EPS (diluted)
$0.21+61.5%Shares Outstanding (diluted)
21.89M-11.3%Operating Expenses
$0.00Cash & Debt
$3.63MReturn of Capital
$19.53MDividend per Share
$0.16Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $137.39M | $11.60M | $0.52 |
| 2024 | $143.06M | $24.78M | $1.05 |
| 2023 | $148.58M | $30.97M | $1.26 |
| 2022 | $151.57M | $31.80M | $1.28 |
| 2021 | $147.95M | $37.47M | $1.47 |
| 2020 | $133.28M | $37.26M | $1.48 |
| 2019 | $127.98M | $32.41M | $1.30 |
| 2018 | $119.69M | $30.05M | $1.11 |
| 2017 | $117.56M | $22.94M | $0.54 |
| 2016 | $109.38M | $20.52M | $0.49 |
| 2015 | $102.34M | $17.61M | $0.42 |
| 2014 | $98.84M | $18.16M | $0.44 |
| 2013 | $92.59M | $15.48M | $0.37 |
| 2012 | $86.42M | $15.07M | $2.22 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from NRC's reported EPS growth of -10.6% a year over 13 years.
- EPS in 5 years
- $0.30
- Implied price
- $10.65
- Return from $24.99
- -15.7% a year
To earn 15.0% a year on these assumptions you'd need to buy at $5.30 — -78.8% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 26 | 31 | 36 | 41 | 46 |
|---|---|---|---|---|---|
| -20.6% | -29.8% | -27.3% | -25.1% | -23.1% | -21.3% |
| -15.6% | -25.4% | -22.7% | -20.4% | -18.3% | -16.4% |
| -10.6% | -21.0% | -18.2% | -15.7% | -13.5% | -11.4% |
| -5.6% | -16.6% | -13.6% | -11.0% | -8.6% | -6.5% |
| -0.6% | -12.2% | -9.0% | -6.2% | -3.8% | -1.5% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
50+0.00%Social Signal Score
Mentions (17)
- Newsetftrends.com·3d ago·Neutral
Nuclear Stocks Could Deliver BAAJA Bounces Nuclear energy equities and the related ETFs are enduring a forgettable 2026. But the energy source remains central to the evolution of AI.
View source ↗ - Newsetftrends.com·6d ago·Negative
NRC Issues Permit for Reactors Powering Chemical Plant The Nuclear Regulatory Commission (NRC) issued a construction permit last week for four reactors to be built at a chemical plant in Texas. The Xe-100 high-temperature gas-cooled reactors (HTGRs), designed by X-energy (XE), will provide high-quality steam for use by Dow Chemicals (DOW).
View source ↗ - Newsfool.com·14d ago·Positive
NRC Health: 3 Key Takeaways for Long-Term Investors Total Recurring Contract Value (TRCV) grew 9% YoY to $154M. Over 70% of current customers buy only one NRC Health product.
View source ↗ - Newsglobenewswire.com·18d ago·Neutral
Terra Innovatum Achieves Key NRC Licensing Milestone, Delivers All 18 SOLO™ PSAR Chapters for Readiness Review as it Advances Toward 2027 First Reactor Deployment Delivery of all 18 PSAR chapters for NRC readiness review underscores continued execution across licensing, manufacturing and deployment activities Delivery of all 18 PSAR chapters for NRC readiness review underscores continued execution across licensing, manufacturing and deployment activities
View source ↗ - Newsglobenewswire.com·23d ago·Negative
NRC Completes Landmark Safety Review of X-energy's Xe-100 SMR Final Safety Evaluation Report formally completes NRC safety review Marks completion of both primary reviews required for Construction Permit approval Establishes regulatory precedent to support more efficient licensing of future Xe-100 projects ROCKVILLE, Md., Oct. 30, 2026 (GLOBE NEWSWIRE) -- X-Energy, Inc. (Nasdaq: XE) (“X-energy” or “the Company”), a leading developer of advanced nuclear reactors and fuel technology, today announc…
View source ↗ - Newsnewsfilecorp.com·23d ago·Neutral
RETRANSMISSION: Manganese X Energy Provides Battery Hill High-Purity Manganese Sample for NRC-Led POSCO LMR Cathode Research Project Montreal, Quebec--(Newsfile Corp. - October 30, 2026) - Manganese X Energy Corp. (TSXV: MN) (FSE: 9SC) (TRADEGATE: 9SC) (OTCQB: MNXXF) ("Manganese X" or the "Company") is pleased to announce that it has entered into a collaborative research agreement dated August 18, 2026, with the National Research Council of Canada ("NRC"), E3 Lithium Ltd., NiVolt Technologies In…
View source ↗ - Newsnewsfilecorp.com·23d ago·Neutral
Manganese X Energy Provides Battery Hill High-Purity Manganese Sample for NRC-Led POSCO LMR Cathode Research Project Montreal, Quebec--(Newsfile Corp. - October 30, 2026) - Manganese X Energy Corp. (TSXV: MN) (FSE: 9SC) (TRADEGATE: 9SC) (OTCQB: MNXXF) ("Manganese X" or the "Company") is pleased to announce that it has entered into a collaborative research agreement dated August 18, 2026, with the National Research Council of Canada ("NRC"), E3 Lithium Ltd., NiVolt Technologies Inc., and POSCO Am…
View source ↗ - Newsmarketbeat.com·26d ago·Neutral
National Research Q3 Earnings Call Highlights National Research NASDAQ: NRC, which operates as NRC Health, reported third-quarter revenue growth of 11% to $38 million as a large customer implementation went live on schedule and contributed revenue for the full quarter.
View source ↗ - Newsbusinesswire.com·27d ago·Neutral
NRC Health Launches nQuire Pro, Extending the Reach of Patient-Experience Teams LINCOLN, Neb.--(BUSINESS WIRE)-- #HealthcareAccess--NRC Health, a recognized leader in healthcare experience management, today announced the launch of nQuire Pro, a conversational analytics tool designed to help healthcare organizations expand their capacity to understand patient-experience feedback, quickly identify performance trends, and uncover unseen improvement opportunities. As healthcare organizations face gr…
View source ↗ - Newsfool.com·28d ago·Negative
NuScale Power Trades Below $6 With the Only NRC-Certified Small Modular Reactor Design. Here's Why That Still Isn't Enough. NuScale's small modular reactor has design approval from the U.S. Nuclear Regulatory Commission. The upstart company will need to secure a binding power purchase agreement in the near future.
View source ↗ - Newsglobenewswire.com·31d ago·Neutral
…struction Permit Application and Reactor Procurement, Reaffirms Fully Funded Path to 2027 First-Of-A-Kind Deployment Company shares 12 of 18 draft PSAR chapters with NRC for readiness review, targets remaining six by October 30 Major reactor components secured or under procurement as Company advances toward fully funded 2027 first-of-a-kind deployment NEW YORK, Oct. 22, 2026 (GLOBE NEWSWIRE) -- Terra Innovatum Global N.V. (NASDAQ: NKLR) ("Terra Innovatum" or the "Company"), developer of the SOLO…
View source ↗ - Newsbusinesswire.com·38d ago·Neutral
New NRC Health Research Reveals What Sets High-Performing Health Systems Apart: Turning Patient Feedback Into Action LINCOLN, Neb.--(BUSINESS WIRE)-- #ExperienceManagementEverywhere--Healthcare organizations have more patient feedback, performance dashboards, and experience data at their fingertips than ever before. But new research from NRC Health (NASDAQ: NRC) suggests that what distinguishes high-performing health systems isn't how much information they access. It's how effectively they turn …
View source ↗ - Newsglobenewswire.com·40d ago·Neutral
NANO Nuclear's KRONOS MMR™ Program Advancing Through U.S. NRC Review with the University of Illinois Urbana-Champaign U. of I. and NANO Nuclear have continued technical engagement with the NRC through the ongoing audit process following formal acceptance of the KRONOS MMR ™ Construction Permit Application for review
View source ↗ - Newsnewsfilecorp.com·40d ago·Negative
NANO Nuclear's KRONOS MMR(TM) Program Advancing Through U.S. NRC Review with the University of Illinois Urbana-Champaign U. of I. and NANO Nuclear have continued technical engagement with the NRC through the ongoing audit process following formal acceptance of the KRONOS MMR™ Construction Permit Application for review Continued licensing progress supports NANO Nuclear's previously disclosed expectation for the opportunity to begin initial construction activities in the second half of 2027 New Yo…
View source ↗ - Newsglobenewswire.com·53d ago·Negative
Former U.S. NRC Commissioner and U.S. DOE Nuclear Chief William D. Magwood, IV to Join newcleo's Board of Directors in January 2027 Magwood's experience negotiating nuclear policy with dozens of governments will give newcleo invaluable insight as it licenses its reactor technology in new markets Magwood's experience negotiating nuclear policy with dozens of governments will give newcleo invaluable insight as it licenses its reactor technology in new markets
View source ↗ - Newszacks.com·55d ago·Neutral
NRC Health Trades at a Discount: Should You Buy, Sell or Hold? NRC's rising recurring contract value, expanding sales pipeline and AI-enabled tools support revenue visibility and potential margin improvement.
View source ↗ - Newsprnewswire.com·82d ago·Neutral
Mercy Earns National Honor for Excellence in Patient Experience Mercy of only three large health systems in the nation to earn distinction Mercy earned NRC Health's 2026 Excellence in Patient Experience Award, marking its fifth consecutive year receiving the national honor. Mercy was one of only three large U.S. health systems to receive the designation in 2026.
View source ↗
Earnings
Tue, Feb 2(in 2 months)
Consensus estimate $0.24 per share
Typical surprise +161.7% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Oct 27$0.21 vs $0.18beat
- Tue, Jul 28$0.31 vs $-0.15beat
Estimates and results for NRC via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by NRC officers and directors.
- Bought
- $142k
- Sold
- $60.6m
3 trades
35 trades
- Harrison Shane Rbought
- Freeman Jordan Nicolebought
- Beans Patrick Ebought
- Common Property Trustsold
- Amandla Mk Trustsold
- Amandla Mk Trustsold
- Common Property Trustsold
- Amandla Mk Trustsold
62 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in NRC.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.
